| aB&D | Acidified Bligh and Dyer |
| B&D | Bligh and Dyer |
| CNS | Central nervous system |
| CSF | Cerebrospinal fluid |
| CV | Coefficient of variation |
| DOPAC | 3,4-Dihydroxyphenylacetic acid |
| EMA | the European Medicines Agency |
| ESI | Electrospray ionization |
| FDA | the U.S. Food and Drug Administration |
| GABA | γ-Aminobutyric acid |
| GC-MS | Gas chromatography–mass spectrometry |
| GWAS | Genome-wide association studies |
| 5-HIAA | 5-Hydroxyindole-3-acetic acid |
| HILIC | Hydrophilic interaction liquid chromatography |
| HPLC/UPLC-MS | High-performance/ultra-high-performance liquid chromatography–mass spectrometry |
| HVA | Homovanillic acid |
| ICH M10 | the International Council for Harmonization |
| LLOQ | Lower limit of quantification |
| LLE | Liquid–liquid extraction |
| LOD | Limit of detection |
| MHPG | 3-Methoxy-4-hydroxyphenylglycol |
| MS | Mass spectrometry |
| MSI | the Metabolomics Standards Initiative |
| MS/MS | Tandem mass spectrometry |
| MWAS | Metabolome-wide association study |
| NMR | Nuclear magnetic resonance |
| PCR | Polymerase chain reaction |
| RP | Reversed-phase |
| TOF | Time-of-flight |
| Q | Quadrupole |
| QC | Quality control |
| QQQ | Triple-quadrupole |
| ULOQ | Upper limit of quantification |